Literature DB >> 29446769

Vascular cognitive impairment.

Wiesje M van der Flier1,2, Ingmar Skoog3, Julie A Schneider4, Leonardo Pantoni5, Vincent Mok6, Christopher L H Chen7, Philip Scheltens1.   

Abstract

The term vascular cognitive impairment (VCI) was introduced around the start of the new millennium and refers to the contribution of vascular pathology to any severity of cognitive impairment, ranging from subjective cognitive decline and mild cognitive impairment to dementia. Although vascular pathology is common in elderly individuals with cognitive decline, pure vascular dementia (that is, dementia caused solely by vascular pathology) is uncommon. Indeed, most patients with vascular dementia also have other types of pathology, the most common of which is Alzheimer disease (specifically, the diffuse accumulation of amyloid-β plaques and neurofibrillary tangles composed of tau). At present, the main treatment for VCI is prevention by treating vascular diseases and other risk factors for VCI, such as hypertension and diabetes mellitus. Despite the current paucity of disease-modifying pharmacological treatments, we foresee that eventually, we might be able to target specific brain diseases to prevent cognitive decline and dementia.

Entities:  

Mesh:

Year:  2018        PMID: 29446769     DOI: 10.1038/nrdp.2018.3

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  100 in total

Review 1.  Contributions of Aging to Cerebral Small Vessel Disease.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Annu Rev Physiol       Date:  2019-10-16       Impact factor: 19.318

2.  Neurocognitive disorders in ICD-11: a new proposal and its outcome.

Authors:  Wolfgang Gaebel; Geoffrey M Reed; Robert Jakob
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

Review 3.  Developments in treating the nonmotor symptoms of stroke.

Authors:  Argye E Hillis
Journal:  Expert Rev Neurother       Date:  2020-05-12       Impact factor: 4.618

4.  Free-water metrics in medial temporal lobe white matter tract projections relate to longitudinal cognitive decline.

Authors:  Derek B Archer; Elizabeth E Moore; Niranjana Shashikumar; Logan Dumitrescu; Kimberly R Pechman; Bennett A Landman; Katherine A Gifford; Angela L Jefferson; Timothy J Hohman
Journal:  Neurobiol Aging       Date:  2020-05-12       Impact factor: 4.673

Review 5.  Introduction to ion channels and calcium signaling in the microcirculation.

Authors:  William F Jackson
Journal:  Curr Top Membr       Date:  2020-03-13       Impact factor: 3.049

6.  Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  J Neurovirol       Date:  2019-01-11       Impact factor: 2.643

7.  Physical activity, common brain pathologies, and cognition in community-dwelling older adults.

Authors:  Aron S Buchman; Lei Yu; Robert S Wilson; Andrew Lim; Robert J Dawe; Chris Gaiteri; Sue E Leurgans; Julie A Schneider; David A Bennett
Journal:  Neurology       Date:  2019-01-16       Impact factor: 9.910

Review 8.  Sex as a biological variable in the pathology and pharmacology of neurodegenerative and neurovascular diseases.

Authors:  Pedram Honarpisheh; Louise D McCullough
Journal:  Br J Pharmacol       Date:  2019-05-21       Impact factor: 8.739

9.  HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease.

Authors:  Jackson T Fontaine; Amanda C Rosehart; Anne Joutel; Fabrice Dabertrand
Journal:  Mech Ageing Dev       Date:  2020-10-27       Impact factor: 5.432

10.  Fibrinogen Levels and Cognitive Profile Differences in Patients with Mild Cognitive Impairment.

Authors:  Jung-Min Pyun; Nayoung Ryoo; Young Ho Park; SangYun Kim
Journal:  Dement Geriatr Cogn Disord       Date:  2020-11-03       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.